Watermark
  Back to Search Results

BGB-16673-304

Not yet recruiting

A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Ask to Join

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-16673-304

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT06973187

EudraCT Number Info icon SVG graphic used for tooltips or additional information.

2025-521654-41-00

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Locations

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents